# PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients

> **NCT03374826** · NA · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 125 (estimated)

## Conditions studied

- Breast Cancer
- Breast Neoplasms
- Breast Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Dedicated axillary hybrid PET-MRI

## Key facts

- **NCT ID:** NCT03374826
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-22
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2023-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03374826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03374826, "PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03374826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*